Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 12:12 AM
NCT ID:
NCT04015258
Eligibility Criteria:
Inclusion Criteria:
* Interested in taking part in the study
* Healthy
* Aged 18-60 years (inclusive)
Exclusion Criteria:
* Smoking
* Aged under 18 or over 60
* Blood Pressure ≥ 145/100 mmHg and are taking medication
* Have vascular disease, or other cardiac abnormalities
* Have previously suffered any head injuries, history of seizures or other neurological disorders
* Have any metabolic disorders, malabsorption syndromes or gastrointestinal complications
* Current use of above disease relevant prescription medications (excluding contraception)
* Irregular bowel function (less than 1 bowel movement per day)
* Regularly consume blueberries/blueberry-contained products more than twice per week
* Have regularly used nutritional supplements or medications within the previous 3 months (defined as more than 3 consecutive days or 4 days in total)
* Learning difficulties and dyslexia
* Visual impairment that cannot be corrected with glasses or contact lenses including colour blindness
* Currently suffer from migraines (\> 1 per month)
* Body mass index (BMI) under 18.5 or over 30
* Pregnancy, seeking to become pregnant, or current lactation
* Inability to complete all of the study assessments
* Current participation in other clinical or nutrition intervention studies
* Not proficient in English equivalent to IELTS band 6 or above
* Have any known active infections
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT04015258
Study Brief:
Protocol Section:
NCT04015258